Back to News
Market Impact: 0.2
Consensus Price Target for bioMérieux S.A. - Depositary Receipt Decreased by 24.45% to $9.77
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for bioMérieux S.A. depositary receipts (OTCPK:BMXXY) was revised down 24.45% to $9.77 per share from $12.93, the prior estimate dated June 8, 2026. The article attributes the figures to aggregate analyst targets; it provides no reason for the reduction or reported share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
BIM-0.35
More News
- A lesson from poker tells us not to fold on Meta after its earnings sell-off. Here’s why
- Under-the-radar stocks to play the next leg of the energy trade with oil prices jumping again
- Tesla is falling even after earnings. What analysts are saying
- Meta Platforms beat the Street. Here's why analysts are bullish on the stock
- Why is Bloom Energy stock sliding today?
- Why is Deckers Outdoor stock sliding today?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Reading Conviction in the Tape: What Level 3 Order Book Data Really Tells Discretionary PMs
- AI Tools for CFA Charterholders: An Evidence Standard